Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumor × Trastuzumab × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 46 Stomach Neoplasms 10 Neoplasm Metastasis 6 Esophageal Neoplasms 6 Neoplasms 5 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Colonic Neoplasms 3 Brain Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Rectal Neoplasms 2 Multiple Myeloma 2 Meningeal Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Inflammatory Breast Neoplasms 2 HER2-positive Gastric Cancer 2 HER2-positive Early Breast Cancer 2 HER2-positive Breast Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Anatomic Stage I Breast Cancer AJCC v8 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Solid Cancer 1 Salivary Gland Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Prostatic Neoplasms 1 Patient Preference 1 Pathologic Complete Response 1

Interventions

Injections 3 zimberelimab 1 tumor-cells apoptosis factor, human 1 toripalimab 1 tislelizumab 1 tazemetostat 1 pembrolizumab 1 cemiplimab 1 cedazuridine 1 WW Domain-Containing Oxidoreductase 1 Specimen Handling 1 RE1-silencing transcription factor 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Indocyanine Green 1 Fluorodeoxyglucose F18 1 Doxorubicin 1 Decitabine 1 Cisplatin 1 Cetuximab 1 Carboplatin 1 Blood Specimen Collection 1 Blood Component Removal 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡